Terms: = Lymphoma AND PSA
89 results:
1.
Kim SY; Park JE; Lee HJ; Sim DY; Ahn CH; Park SY; Shim BS; Kim B; Lee DY; Kim SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474045
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results.
Oluwole OO; Ray MD; Davies N; Bradford R; Jones C; Patel AR; Locke FL
J Med Econ; 2024; 27(1):230-239. PubMed ID: 38240256
[TBL] [Abstract] [Full Text] [Related]
3. Deregulation of miR-10b and miR-21 Correlate with Cancer Stem Cells Expansion through the Apoptotic Pathway in Prostate Cancer.
Shukla KK; Choudhary GR; Sankanagoudar S; Misra S; Vishnoi JR; Pareek P; Pilla KK; Pandey SN; Sharma P
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2105-2119. PubMed ID: 37378942
[TBL] [Abstract] [Full Text] [Related]
4. Vitamin D and Autoimmune Rheumatic Diseases.
Athanassiou L; Kostoglou-Athanassiou I; Koutsilieris M; Shoenfeld Y
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189455
[TBL] [Abstract] [Full Text] [Related]
5. Prophylaxis for
Huang X; Huang X; Lin S; Luo S; Dong L; Lin D; Huang Y; Xie C; Nian D; Xu X; Weng X
BMJ Open; 2023 Mar; 13(3):e068943. PubMed ID: 36972963
[TBL] [Abstract] [Full Text] [Related]
6. Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort study.
Eun Y; Hwang J; Seo GH; Ahn JK
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36958767
[TBL] [Abstract] [Full Text] [Related]
7. Bilateral Adrenal and testicular Tumours; When a Simple Diagnosis Becomes Complicated.
Grootemaat M; Tjiam I; Sampimon D; Bot F; Roshani H
Urology; 2023 May; 175():e11-e12. PubMed ID: 36828262
[TBL] [Abstract] [Full Text] [Related]
8. [Prostatic lymphoma: a rare cause of urinary retention (a case report)].
Namaoui RY; Benremouga MC; Boutoura S; Rahali MC; Hadjaoui W; Zerabib A; Belbekri L; Zar F; Berrah H; Mouats A; Bessaïh A
Pan Afr Med J; 2022; 43():33. PubMed ID: 36505021
[TBL] [Abstract] [Full Text] [Related]
9. Practice changing data and emerging concepts from recent radiation therapy randomised clinical trials.
Espenel S; Chargari C; Blanchard P; Bockel S; Morel D; Rivera S; Levy A; Deutsch E
Eur J Cancer; 2022 Aug; 171():242-258. PubMed ID: 35779346
[TBL] [Abstract] [Full Text] [Related]
10. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
[TBL] [Abstract] [Full Text] [Related]
11. Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States.
Alrawashdh N; McBride A; Slack M; Persky D; Andritsos L; Abraham I
J Manag Care Spec Pharm; 2022 Apr; 28(4):390-400. PubMed ID: 35332792
[No Abstract] [Full Text] [Related]
12. Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Husni ME; Deodhar A; Schwartzman S; Chakravarty SD; Hsia EC; Leu JH; Zhou Y; Lo KH; Kavanaugh A
Arthritis Res Ther; 2022 Mar; 24(1):73. PubMed ID: 35313978
[TBL] [Abstract] [Full Text] [Related]
13. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y; Huang Q; Li X; Zheng X; Liu M
Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
[TBL] [Abstract] [Full Text] [Related]
14. Intravascular large B cell lymphoma of prostate, a rare entity.
Rallabandi HB; Thirukovela J; Swain M; Meeramira D; Gowrishankar S
Indian J Pathol Microbiol; 2021; 64(3):575-578. PubMed ID: 34341277
[TBL] [Abstract] [Full Text] [Related]
15. Penile secondary lesions: a rare entity detected by PET/CT.
Davidson T; Domachevsky L; Giladi Y; Fridman E; Dotan Z; Rosenzweig B; Leibowitz R; Ben Shimol J
Sci Rep; 2021 Mar; 11(1):5912. PubMed ID: 33723317
[TBL] [Abstract] [Full Text] [Related]
16. Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States.
Liu R; Oluwole OO; Diakite I; Botteman MF; Snider JT; Locke FL
J Med Econ; 2021; 24(1):458-468. PubMed ID: 33691581
[TBL] [Abstract] [Full Text] [Related]
17. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
[TBL] [Abstract] [Full Text] [Related]
18. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
[TBL] [Abstract] [Full Text] [Related]
20. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
[TBL] [Abstract] [Full Text] [Related]
[Next]